Alejandro Restrepo, M.D.
Assistant Professor of Medicine
M.D., Instituto de Ciencias de la Salud-CES, Colombia
Residency, Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania
Fellowship, Infectious Diseases, University of Rochester Medical Center, Rochester, New York
Fellowship, Transplant Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts
Selected Publications:
Arango JI, Restrepo A, Schneider DL, Callander NS, Ochoa-Bayona JL, Restrepo MI, Bradshaw P, Patterson J, Freytes CO. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant. 2006 Mar;37(5):517-21
Cesar O. Freytes, Voravit Ratanatharathorn, Charles Taylor, Camille Abboud, Nancy Chesser, Alejandro Restrepo, Jorge Arango and Daniel Odenheimer . Phase I/II Randomized Trial Evaluating the Safety and Clinical Effects of Repifermin (KGF-2) Administered to Reduce Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation , Clinical Cancer Research. 2004 Dec; 10: 8318-8324
Restrepo, A, Devore, P, Encarnación, C, Wholey, MH, Scneider, DL, Callander, NS, Ferral, H, Postoak, D, Anderson, JE, Walsh, T, Padayao, G, Gokmen, E, Eshan, A, Ochoa, L, Neumon, B, West, G, Restrepo, MI, Przykucki, J, Patterson, J, Freytes, CO. Performance of a hybrid central venous catheter utilized for both peripheral blood stem cell harvest and transplant support of patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2002 Sep;30(6):389-95
Having problems
with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for
Research and Therapy, University of Arkansas for Medical Sciences Terms and Conditions of Use
The information on the Myeloma Institute web site
is not intended as a substitute for professional medical attention. The
information is intended only as an aid in understanding current medical
knowledge. A physician should always be consulted for any health concern or
medical condition. The Myeloma Institute web site provides links to other
organizations as a service to our readers. The Myeloma Institute is not
responsible for the information provided on other web sites.